glp-1 and addiction medications are getting attention for their potential in care. Here's what the research is finding. #AddictionTreatment #GLP1 #EmergingResearch GLP-1s like Ozempic transformed weight

Incretin impact on gastric function in obesity: physiology, and pharmacological, surgical and endoscopic treatments

Low-dose naltrexone (LDN) has shown promise for mental health, though it is not a first-line treatment

They typically resolve or become manageable within 2-4 weeks at each new dose level

Fluid Composition: Some people are sensitive to specific electrolytes or ingredients in IV solutions, such as sodium chloride or potassium

Experimental Explorations Localized recovery: Tissue-specific actions suit targeted muscle repair models

The muscle pieces were then fragmented further by sonication (Branson) at maximum power and 50% duty cycle for 20 s